← All indications
Hyaline Membrane Disease
A respiratory distress syndrome in newborn infants, usually premature infants with insufficient PULMONARY SURFACTANTS. The disease is characterized by the formation of a HYALINE-like membrane lining the terminal respiratory airspaces (PULMONARY ALVEOLI) and subsequent collapse of the lung (PULMONARY ATELECTASIS).
Drugs by status
Phase 4 trials (4)
Phase 3 trials (1)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (1)
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (10)
- Azienda Ospedaliera San Gerardo di Monza
- Monash University
- University of Florence
- University of Milan
- Marche Polytechnic University
- University of Amsterdam
- Instituto de Medicina Integral Professor Fernando Figueira
- Catholic University of Sacred Heart, Rome
- Centre for Neonatal Research and Education, Crawley, West Australia
- Ahmadu Bello University